Registration for our upcoming #webinar, 7th May, is open! Join us to learn more from global industry leaders, as we discuss #mutations occurring around the world, and what the future holds for #diagnostic testing. bit.ly/3n5jrHM #Novacyt

We are delighted to announce our partnership with UNICEF to support them in their work with government and the #COVID19 Tools Accelerator Programme. To find out more: bit.ly/3vzMGFC #Novacyt

It’s nearly here! Just 3 days to go until our live #webinar on global #mutations and the role of #diagnostic testing during this #pandemic. We look forward to seeing you there! bit.ly/3n5jrHM #Novacyt #COVID19

We are delighted to be supporting UNICEF in their work with government and Access to #COVID-19 Tools Accelerator: bit.ly/3vzMGFC UNICEF France UNICEF UK #Novacyt

#Novacyt encourages other partners to join and support UNICEF’s role in the #COVID-19 Tools Accelerator. No one is safe until everyone is safe! UNICEF France UNICEF UK

We are delighted to have successfully added our SARS-CoV-2 service (using the Primerdesign Ltd Genesig Assay) to our UKAS accreditation – ISO 15189 - the international Quality standard for medical laboratory testing. Read more: - camclinlabs.co.uk/news/accredita…

Our SNPsig® kits use our own proprietary #genotyping method, enabling the identification of SARS-CoV-2 #variants . These products can be used as reflex testing resulting in exceptional genotyping data: bit.ly/2NQcWuS #Novacyt #COVID19

Our SNPsig® #COVID19 innovation provides an alternative to next generation #sequencing, enabling scientists to analyse and monitor specific #genomic #mutations. Talk to our team to find out more: [email protected] #Novacyt #NCYT

Our #VersaLab portfolio just got stronger. Check out the all-new VersaLab™ Portable that enables rapid #COVID19 #PCR testing on-site. bit.ly/3mmrpLr #Novacyt #NCYT #closertopatient

With yet more products being added to our rapidly growing portfolio of #COVID19 products, we thought the announcement of the launches of our genesig® COVID-19 3G (CE-IVD) and SNPsig® EscapePLEX SARS-CoV-2 was worth shouting about with a video! #Novacyt #NCYT

#VersaLab aspires to support private sector testing of infectious diseases, initially focused on #COVID19. Contact us to find out more on the proven capabilities VersaLab™ Portable can provide to COVID-19 testing: [email protected] #Novacyt #NCYT #closertopatient

#COVID19 testing at your fingertips. With #VersaLab Portable you can analyse results wherever you are in under 80 minutes. Ask our team for further information: [email protected] #Novacyt #NCYT #closertopatient

Did you know: Our SNPsig® EscapePLEX can detect the Delta (India) #VariantofConcern, known for its high transmission rates and widescale spread in India and other countries. #Novacyt #NCYT #COVID19

#NovacytGroup has a world class #bioinformatics team. We have the ability and skill to determine and identify all relevant #COVID19 #variants. #Novacyt #NCYT

#VersaLab Portable includes a genesig® q16 workflow, packed neatly in a lightweight carry case, providing testing with Gold standard PCR results, from optimised reagents. Contact us to enquire today: [email protected] #Novacyt #NCYT #COVID19 #closertopatients

Enhancing the way we test for #VariantsofConcern, SNPsig® EscapePLEX is intended for use as a reflex test for positive samples of multiple #COVID19 #mutations. Contact our team to find out more: [email protected] #Novacyt #NCYT

Our SNPsig® portfolio enables the detection of various #COVID19 #mutations, providing a variety of tests capable of detecting one, or multiple #variants at once. Find out more about SNPsig®’s full portfolio bit.ly/2NQcWuS #Novacyt #NCYT

genesig® 3G opens the opportunity for testing in a variety of settings, including the travel industry, with Fit to Fly Certificate, Test to Release and FDA regulations. Find out more today: [email protected] #Novacyt #NCYT #COVID19

Outbreaks of the #DeltaVariant have been identified in over 70 countries. However, it's not the only #COVID19 variant that is worrying. Here's an easy-to-digest infographic highlighting the #VariantsofConcern, that #Novacyt's SNPsig® portfolio can detect. #NCYT

As of 13 October 2021, we will be closing this page, moving all activity to Novacyt. Thank you to all our followers for your continued support; we hope you’ve found this channel useful and look forward to welcoming you to our dedicated #Novacyt page!